<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03648541</url>
  </required_header>
  <id_info>
    <org_study_id>1368-0017</org_study_id>
    <secondary_id>2018-000334-35</secondary_id>
    <nct_id>NCT03648541</nct_id>
  </id_info>
  <brief_title>BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis</brief_title>
  <official_title>An Open Label, Long Term Safety Trial of BI 655130 Treatment in Patients With Moderate to Severely Active Ulcerative Colitis Who Have Completed Previous BI 655130 Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the long-term safety of Spesolimab in patients with moderate to severely active
      ulcerative colitis, who have completed treatment in previous trials To evaluate the long-term
      efficacy of Spesolimab in patients with moderate to severely active ulcerative colitis, who
      have completed treatment in previous trials
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Anticipated">March 30, 2031</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2031</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The exposure adjusted rate of patients reporting a treatment emergent adverse event (TEAE)</measure>
    <time_frame>Up to week 336</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with clinical remission</measure>
    <time_frame>Up to 336 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">79</enrollment>
  <condition>Colitis, Ulcerative</condition>
  <arm_group>
    <arm_group_label>All Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 arm solution for injection Spesolimab will be used for all patients. Those who did not respond to previous induction treatment or experienced disease flare will need i.v. re-induction treatment also</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spesolimab IV infusion</intervention_name>
    <description>Solution for infusion</description>
    <arm_group_label>All Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spesolimab SC solution for injection</intervention_name>
    <description>Solution for injection</description>
    <arm_group_label>All Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients, aged ≥18 years

          -  Signed and dated written informed consent for 1368.17, in accordance with GCP and
             local legislation prior to admission into the trial

          -  Women of childbearing potential (WOCBP) must be ready to use highly effective methods
             of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per
             year when used consistently and correctly. A list of contraception methods meeting
             these criteria is provided in the patient information. Note: A woman is considered of
             childbearing potential (WOCBP), i.e. fertile, following menarche and until becoming
             postmenopausal unless permanently sterile. Permanent sterilisation methods include
             hysterectomy, bilateral salpingectomy and bilateral oophorectomy. Tuba ligation is NOT
             a method of permanent sterilisation. A postmenopausal state is defined as no menses
             for 12 months without an alternative medical cause.

          -  Have completed treatment and the EOT visit in the previous trial and are willing and
             able to continue treatment in 1368.17.

        Exclusion Criteria:

          -  Have experienced study treatment-limiting adverse events during induction treatment
             with study drug

          -  Have developed any of the exclusion criteria from the original induction study with
             the following exceptions:

               -  Cases of disease limited to the rectum extending &lt;15 cm past the anal verge are
                  allowed to be included in study 1368.17

               -  Cases of latent TB. Patients with newly emerging latent TB during preceding study
                  are allowed to be included in study 1368.17, provided they receive appropriate
                  treatment according to local guidelines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boehringer Ingelheim</last_name>
    <phone>1-800-243-0127</phone>
    <email>clintriage.rdg@boehringer-ingelheim.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Research Center of Connecticut, LLC</name>
      <address>
        <city>Hamden</city>
        <state>Connecticut</state>
        <zip>06518</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Ginsburg</last_name>
      <phone>+001 (203) 281-5161</phone>
      <email>pginsburg@gastrocenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heba Iskandar</last_name>
      <phone>+001 (404) 778-3184</phone>
      <email>heba.iskandar@emoryhealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Russell Cohen</last_name>
      <phone>+001 (773) 834-7414</phone>
      <email>rcohen@medicine.bsd.uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center-New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Digestive Disease Specialists Inc</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew McBride</last_name>
      <phone>+001 (405) 702-1246</phone>
      <email>matthew.mcbride@okddsi.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Horst</last_name>
      <phone>+001 (615) 322-7403</phone>
      <email>sara.n.horst@vanderbilt.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southern Star Research Institute, LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Bullock</last_name>
      <phone>+001 (210) 271-0606</phone>
      <email>js_bull@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Digestive Disease Consultants - Southlake</name>
      <address>
        <city>Southlake</city>
        <state>Texas</state>
        <zip>76092</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Ritter</last_name>
      <phone>+001 (806) 341-6347</phone>
      <email>tritter@tddctx.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Gaidos</last_name>
      <phone>+001 (804) 675-6789</phone>
      <email>Jill.Gaidos@va.gov</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ordensklinikum Linz GmbH - Barmherzige Schwestern</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>AKH - Medical University of Vienna</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Victoria Hospital (LHSC)</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Ponich</last_name>
      <phone>519-685-8500 x77597</phone>
      <email>Terry.Ponich@LHSC.ON.CA</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Neurath</last_name>
      <phone>+49 (9131) 8535204</phone>
      <email>Markus.Neurath@uk-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Esslingen GmbH</name>
      <address>
        <city>Esslingen</city>
        <zip>73730</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Geißler</last_name>
      <phone>+49 (711) 3103 2450</phone>
      <email>m.geissler@klinikum-esslingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asklepios Kliniken Westklinikum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>22559</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ursula Seidler</last_name>
      <phone>+49 (511) 5329427</phone>
      <email>Seidler.Ursula@MH-Hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Schreiber</last_name>
      <phone>+49 (431) 50015101</phone>
      <email>s.schreiber@mucosa.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Klaus</last_name>
      <phone>+49 (731) 50044727</phone>
      <email>jochen.klaus@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edoardo Savarino</last_name>
      <phone>+39 (049) 8215658</phone>
      <email>edoardosavarino@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano (MI)</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvio DANESE</last_name>
      <phone>+39 (02) 82244542</phone>
      <email>IBDclinicaltrials@humanitas.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sapporo Tokushukai Hospital</name>
      <address>
        <city>Hokkaido, Sapporo</city>
        <zip>004-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toshifumi Ashida</last_name>
      <phone>+81 11 8901110</phone>
      <email>ashida-sapporo@tmc-sp.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sapporo Higashi Tokushukai Hospital</name>
      <address>
        <city>Hokkaido, Sapporo</city>
        <zip>065-0033</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atsuo Maemoto</last_name>
      <phone>+81 11 7221110</phone>
      <email>maemoto@tohtoku.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine Hospital</name>
      <address>
        <city>Hyogo, Nishinomiya</city>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoko Yokoyama</last_name>
      <phone>+81 798 456111</phone>
      <email>yoko0502@hyo-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ofuna Chuo Hospital</name>
      <address>
        <city>Kanagawa, Kamakura</city>
        <zip>247-0056</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yutaka Endo</last_name>
      <phone>+81 467 452111</phone>
      <email>y_endo2014@yahoo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical and Dental University</name>
      <address>
        <city>Tokyo, Bunkyo-ku</city>
        <zip>113-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toshimitsu Fujii</last_name>
      <phone>+81 3 38136111</phone>
      <email>tfujgast@tmd.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Yamate Medical Center</name>
      <address>
        <city>Tokyo, Shinjuku</city>
        <zip>169-0073</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naoki Yoshimura</last_name>
      <phone>+81 3 33640251</phone>
      <email>nyoshimura_chiken@yahoo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inje University Haeundae Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>48108</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae-Oh Kim</last_name>
      <phone>82 10 9330 2333</phone>
      <email>kto0440@paik.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>42415</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byung Ik Jang</last_name>
      <phone>82 53 620 3830</phone>
      <email>jbi@med.yu.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03181</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Il Park</last_name>
      <phone>82 2 2001 8555</phone>
      <email>diksmc.park@samsung.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Hee Cheon</last_name>
      <phone>82 2 2228 1990</phone>
      <email>geniushee@yuhs.ac</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, St.Vincent's Hospital</name>
      <address>
        <city>Suwon</city>
        <zip>16247</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kang-Moon Lee</last_name>
      <phone>82 31 249 8151</phone>
      <email>drmaloman@catholic.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Clinical Hospital MSWiA, Internal Diseases, Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>FSB Instit. HC Irkutsk Scient.Cent. Sibirian Branch of Russ. Acad. Scien.</name>
      <address>
        <city>Irkutsk</city>
        <zip>664033</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution &quot; State Scientific Center of Coloproctology&quot; MOH Russia</name>
      <address>
        <city>Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>The limited liability company &quot;Clinic USI 4D&quot;</name>
      <address>
        <city>Pyatigorsk</city>
        <zip>357502</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darya Saenko</last_name>
      <phone>+7 919 752 6202</phone>
      <email>dashavita@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy n.a. C. M. Kirov, St. Petersburg</name>
      <address>
        <city>St. Petersburg</city>
        <zip>194044</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Leo Carnerero</last_name>
      <phone>+34955012065</phone>
      <email>ELEOC@TELEFONICA.NET</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Politècnic La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belén Beltrán Niclos</last_name>
      <phone>+34961244000</phone>
      <email>belenbeltranniclos@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barnsley Hospital</name>
      <address>
        <city>Barnsley</city>
        <zip>S75 2EP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kapil Kapur</last_name>
      <phone>01226 432542</phone>
      <email>kapil.kapur@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doncaster Royal Infirmary</name>
      <address>
        <city>Doncaster</city>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anurag Agrawal</last_name>
      <phone>01302 644429</phone>
      <email>anurag.agrawal1@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Irving</last_name>
      <phone>02071882499</phone>
      <email>peter.irving@gstt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Whiston Hospital</name>
      <address>
        <city>Prescot</city>
        <zip>L35 5DR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajiv Chandy</last_name>
      <phone>+44 151 426 1600</phone>
      <email>Rajiv.chandy@sthk.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 24, 2018</study_first_submitted>
  <study_first_submitted_qc>August 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2018</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Clinical studies sponsored by Boehringer Ingelheim, phases I to IV, interventional and non-interventional, are in scope for sharing of the raw clinical study data and clinical study documents, except for the following exclusions:
Studies in products where Boehringer Ingelheim is not the license holder;
studies regarding pharmaceutical formulations and associated analytical methods, and studies pertinent to pharmacokinetics using human biomaterials;
Studies conducted in a single center or targeting rare diseases (because of limitations with anonymization).
Requestors can use the following link http:// trials.boehringer-ingelheim.com/ to:
find information in order to request access to clinical study data, for listed studies.
request access to clinical study documents that meet criteria, and upon a signed 'Document Sharing Agreement.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

